Your allocation to the healthcare sector is considerably low. What is your take on the sector going forward? |
Our exposure to sectors is based on relative valuations and we are optimistic about the healthcae sector. The generics market is expected to grow, aided by patent expiries. |
Indian companies with access to a large pool of skilled chemists and approved manufacturing facilities will have an advantage. |
You have substantial exposure to technology and automobiles. What makes these two sectors attractive? |
At current levels, leading technology companies are attractively valued given their long-term growth potential. Continuing economic expansion and rise in per capita GDP numbers are expected to aid the automobile sector. |
What is the fund's strategy in the current market scenario? |
The change in sentiment offers good buying opportunities for long-term investors like us given that there has been no change in fundamentals. |
We will focus on quality stocks across sectors to build a portfolio that can deliver over market cycles. |
What is your outlook for the stock markets? |
Given the strong fundamentals, at current levels, the equity markets look undervalued and attractive for investments with a three-five year horizon. |
We expect the markets to remain volatile over the short term. But the long-term story continues to be robust. |